Understanding the experiences of advanced breast cancer patients and their caregivers in Spain
Ethnographic Study on Advanced Breast Cancer Patients and Their Caregivers in Spain
This study is trying to understand the experiences and needs of patients with advanced breast cancer and their caregivers in Spain to find better ways to support them during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Gilead Sciences Industry-sponsored |
| Locations | 1 site (Barcelona, Catalonia) |
| Trial ID | NCT06683482 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather qualitative data on the psychosocial needs of patients with advanced breast cancer and their caregivers in Spain. By conducting interviews, the study seeks to capture a holistic view of their behaviors, actions, and perspectives. The insights gained will help identify strategies to improve the support and care provided to these individuals. The study focuses on patients diagnosed with specific types of advanced breast cancer who have started their first-line treatment.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with confirmed advanced breast cancer who can participate in interviews.
Not a fit: Patients unable to collaborate due to mental status alterations or language comprehension issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved support strategies for advanced breast cancer patients and their caregivers.
How similar studies have performed: While qualitative studies on cancer care exist, this specific ethnographic approach focusing on advanced breast cancer in Spain may offer novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Key Inclusion Criteria: 1. Informed consent to individual in the qualitative study and to allow the recording of the interview for analyses purposes (individual and/or caregiver). 2. Women or men (individual and/or caregiver) over 18 years of age. 3. Confirmed diagnosis of triple-negative breast cancer (TNBC), hormone receptor (HR)+/ human epidermal growth factor receptor 2 (HER2)-, HER2+ unresectable locally advanced breast cancer (ULABC) or metastatic breast cancer (mBC) (individual). 4. Individuals must have initiated at least the firstline treatment. 5. Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale 0-2 (individual). 6. Ability to conduct interviews from home (individual and/or caregiver) or remotely (ie, with technology available for an online interview). Key Exclusion Criteria: 1. Individual unable to collaborate in the collection of necessary information (alteration in mental status, noncollaboration, limited language comprehension). 2. Individual unable or unwilling to provide informed consent. Note: Other protocol defined Inclusion/Exclusion criteria may apply
Where this trial is running
Barcelona, Catalonia
- Salvetti & Llombart Sl — Barcelona, Catalonia, Spain (Recruiting)
Study contacts
- Study coordinator: Gilead Clinical Study Information Center
- Email: GileadClinicalTrials@gilead.com
- Phone: 1-833-445-3230 (GILEAD-0)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.